INS and endometrial cancer: When combining pairs of mediators together into a single model, we found evidence that an effect of fasting insulin on endometrial cancer was partially mediated by SHBG levels and that an effect of SHBG on endometrial cancer was largely mediated by bioavailable testosterone levels.